The report described a 34-year-old woman diagnosed with an undifferentiated tumor exhibiting SMARCA4 deficiency, which demonstrated a fusion mutation involving EML4 exon 13 and ALK exon 20. This evidence concerns the gene EML4 and neoplasm.